SUNPHARMA acquisition, merger or stake sale
as of Sat 20 Jun 15:30
SUN PHARMACEUTICAL IND L filed acquisition, merger or stake sale of ₹271 crore, from Innovcare Lifesciences Private Limited, its own share being 100% on Sat 20 Jun 2026.
Its size: <1% of the company's market value.
Where it came from
as of Sat 20 Jun 15:30
Sources
- Filed
- NSE · 2026-06-20 17:23 IST
- Document
raw/nse_announcement_docs/2026-06-20/d78c7c0b2eea_d78c7c0b2eea_SUNSEC_20062026172244_SE_Intimation_Ivy_finalsigned.pdf· SHA-256 d78c7c0b2eea- Read from
- “Cash consideration aggregating ~Rs 271.2 Crores.” · page 2 · characters 3744–3792
- Read by
- claude-haiku-4-5 · prompt 8c43350f344fef0c · 10 of 10 checks passed
- Measured against
- the company’s market value · as of 19 Jun 2026
- Kind
- acquisition, merger or stake sale
What such filings have been followed by
as of Sat 20 Jun 15:30
| Over | In | Beyond its normal day | Beyond what options priced |
|---|---|---|---|
| This stock | the next session | 1 of 5 | 3 of 5 |
| This stock | the next five sessions | 1 of 5 | 3 of 5 |
| Its industry (Healthcare) | the next session | 4 of 46 | 25 of 46 |
| Its industry (Healthcare) | the next five sessions | 6 of 45 | 19 of 45 |
| Every stock | the next session | 74 of 585 | 275 of 585 |
| Every stock | the next five sessions | 86 of 581 | 267 of 573 |
Counts of past filings of the same kind and size: of how many, how many were followed by a move bigger than the stock's own normal day, and bigger than what its options priced for the same span. A greyed row has fewer than 30 cases, too few to read as a tendency, and its counts are printed anyway. A filing whose sessions have not all arrived is not counted.